Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Humphreys

Showing results (351-360 of 450) with videos related to

Pageof 45
Sort By:
Plos Medicine|May 5, 2006
Linkage disequilibrium mapping of CHEK2: common variation and breast cancer riskKristjana Einarsdóttir, Keith Humphreys, Carine Bonnard, et al.
Addiction Science & Clinical Practice|November 2, 2015
Predictive validity of two process-of-care quality measures for residential substance use disorder treatmentAlex H S Harris, Shalini Gupta, Thomas Bowe, et al.
Lancet Regional Health. Americas|March 28, 2022
Sociodemographic and geographic disparities in excess fatal drug overdoses during the COVID-19 pandemic in California: A population-based studyMathew V Kiang, Rolando J Acosta, Yea-Hung Chen, et al.
Breast Cancer Research : BCR|June 26, 2004
Oestrogen receptor alpha gene haplotype and postmenopausal breast cancer risk: a case control studySara Wedrén, Lovisa Lovmar, Keith Humphreys, et al.
Drug and Alcohol Dependence|August 18, 2020
Impact of 12 step mutual help groups on drug use disorder patients across six clinical trialsKeith Humphreys, Nicolas B Barreto, Sheila M Alessi, et al.
Frontiers in Human Neuroscience|August 6, 2025
Effects of intermittent theta burst to the left dorsolateral prefrontal cortex on brain volumes and neurometabolites in people with alcohol use disorder: a preliminary investigationTimothy C Durazzo, Lauren H Beauregard, Meng Gu, et al.
Water Research|August 21, 2023
Monitoring medication and illicit drug consumption in a prison by wastewater-based epidemiology: Impact of COVID-19 restrictionsZhe Wang, Jochen F Mueller, Jake W O'Brien, et al.
JAMA Health Forum|May 19, 2023
Cost-effectiveness of Increasing Buprenorphine Treatment Initiation, Duration, and Capacity Among Individuals Who Use OpioidsAnneke L Claypool, Catherine DiGennaro, W Alton Russell, et al.
JAMA Psychiatry|March 31, 2021
Cost-effectiveness of Treatments for Opioid Use DisorderMichael Fairley, Keith Humphreys, Vilija R Joyce, et al.
Substance Abuse|July 21, 2016
Predictive validity of a quality measure for intensive substance use disorder treatmentEric M Schmidt, Shalini Gupta, Thomas Bowe, et al.
Pageof 45

Showing results (351-360 of 450) with videos related to

Sort By:
Pageof 45
Plos Medicine|May 5, 2006
Linkage disequilibrium mapping of CHEK2: common variation and breast cancer riskKristjana Einarsdóttir, Keith Humphreys, Carine Bonnard, et al.
Addiction Science & Clinical Practice|November 2, 2015
Predictive validity of two process-of-care quality measures for residential substance use disorder treatmentAlex H S Harris, Shalini Gupta, Thomas Bowe, et al.
Lancet Regional Health. Americas|March 28, 2022
Sociodemographic and geographic disparities in excess fatal drug overdoses during the COVID-19 pandemic in California: A population-based studyMathew V Kiang, Rolando J Acosta, Yea-Hung Chen, et al.
Breast Cancer Research : BCR|June 26, 2004
Oestrogen receptor alpha gene haplotype and postmenopausal breast cancer risk: a case control studySara Wedrén, Lovisa Lovmar, Keith Humphreys, et al.
Drug and Alcohol Dependence|August 18, 2020
Impact of 12 step mutual help groups on drug use disorder patients across six clinical trialsKeith Humphreys, Nicolas B Barreto, Sheila M Alessi, et al.
Frontiers in Human Neuroscience|August 6, 2025
Effects of intermittent theta burst to the left dorsolateral prefrontal cortex on brain volumes and neurometabolites in people with alcohol use disorder: a preliminary investigationTimothy C Durazzo, Lauren H Beauregard, Meng Gu, et al.
Water Research|August 21, 2023
Monitoring medication and illicit drug consumption in a prison by wastewater-based epidemiology: Impact of COVID-19 restrictionsZhe Wang, Jochen F Mueller, Jake W O'Brien, et al.
JAMA Health Forum|May 19, 2023
Cost-effectiveness of Increasing Buprenorphine Treatment Initiation, Duration, and Capacity Among Individuals Who Use OpioidsAnneke L Claypool, Catherine DiGennaro, W Alton Russell, et al.
JAMA Psychiatry|March 31, 2021
Cost-effectiveness of Treatments for Opioid Use DisorderMichael Fairley, Keith Humphreys, Vilija R Joyce, et al.
Substance Abuse|July 21, 2016
Predictive validity of a quality measure for intensive substance use disorder treatmentEric M Schmidt, Shalini Gupta, Thomas Bowe, et al.
Pageof 45